(Photo courtesy of CHOP)
The two institutions had already connected for a year-long pilot application of Blackfynn’s data analytics platform for neuroscience research. That period has now been extended to an indeterminate amount of time.
According to the renewed agreement, the system will also be used by both CHOP and the Children’s Brain Tumor Tissue Consortium (CBTTC) to “bring together complex non-identifiable patient data for collaboration and analysis” for pediatric brain cancer research.
Though founder Amanda Christini declined to comment on the financial detail she did say the partnership now allows for an expanded use of the platform, including multiple vertients of data.
“We are thrilled to expand our relationship with CHOP, whose commitment to enabling translational research through collaboration and data access inspires us every day,” said Christini in a press release. “We share their core belief that transformational discovery will only occur when experts can effectively use the vast amounts of disparate, complex data generated in research. Blackfynn’s Data Platform will fundamentally enable this goal.”-30-
Old City medtech startup Strados Labs set to hire after raising $1.8M
JP Morgan Chase scoops up InstaMed, but the healthcare-tech company isn’t leaving Philly
Get access to 100 services on the new website for Philly’s health department
This apprenticeship program is opening the door for candidates with nontraditional backgrounds
How a Philly company is building online communities around chronic conditions
Could this ‘momentous’ data dump save millions of kids from cancer?
This IBX Foundation campaign looks to destigmatize opioid addiction
How AI can help humans, not replace them
Sign-up for daily news updates from Technical.ly Philadelphia